Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Patterson

Showing results (261-270 of 277) with videos related to

Pageof 28
Sort By:
Journal of the American Heart Association|October 6, 2021
Sacubitril/Valsartan Initiation Among Veterans Who Are Renin-Angiotensin-Aldosterone System Inhibitor Naïve With Heart Failure and Reduced Ejection FractionApril F Mohanty, Emily B Levitan, Jordan B King, et al.
The Lancet. Healthy Longevity|July 23, 2021
Association between HIV and incident pulmonary hypertension in US Veterans: a retrospective cohort studyMeredith S Duncan, Charles W Alcorn, Matthew S Freiberg, et al.
EGEMS (Washington, DC)|June 9, 2018
A Framework for Leveraging "Big Data" to Advance Epidemiology and Improve Quality: Design of the VA Colonoscopy CollaborativeSamir Gupta, Lin Liu, Olga V Patterson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 29, 2005
Cancer chemotherapy and drug metabolismDavid S Riddick, Chunja Lee, Shairoz Ramji, et al.
Analytical Chemistry|April 8, 2020
Virus Bioresistor (VBR) for Detection of Bladder Cancer Marker DJ-1 in Urine at 10 pM in One MinuteApurva Bhasin, Emily C Sanders, Joshua M Ziegler, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2021
Restoring Tumour Selectivity of the Bioreductive Prodrug PR-104 by Developing an Analogue Resistant to Aerobic Metabolism by Human Aldo-Keto Reductase 1C3Maria R Abbattista, Amir Ashoorzadeh, Christopher P Guise, et al.
Molecular Cancer Therapeutics|December 8, 2011
Molecular and cellular pharmacology of the hypoxia-activated prodrug TH-302Fanying Meng, James W Evans, Deepthi Bhupathi, et al.
American Journal of Respiratory and Critical Care Medicine|November 14, 2017
Increased Echocardiographic Pulmonary Pressure in HIV-infected and -uninfected Individuals in the Veterans Aging Cohort StudyEvan L Brittain, Meredith S Duncan, Joyce Chang, et al.
Acta Pharmacologica Sinica|June 23, 2026
Development of XYD113 as a potent and highly selective GSPT1 degrader for cancer therapyHui Shen, Xiao-Yu Luo, Xin-Yi Jing, et al.
Biochemical Pharmacology|January 18, 2014
A novel fluorometric assay for aldo-keto reductase 1C3 predicts metabolic activation of the nitrogen mustard prodrug PR-104A in human leukaemia cellsStephen M F Jamieson, Yongchuan Gu, Donya Moradi Manesh, et al.
Pageof 28

Showing results (261-270 of 277) with videos related to

Sort By:
Pageof 28
Journal of the American Heart Association|October 6, 2021
Sacubitril/Valsartan Initiation Among Veterans Who Are Renin-Angiotensin-Aldosterone System Inhibitor Naïve With Heart Failure and Reduced Ejection FractionApril F Mohanty, Emily B Levitan, Jordan B King, et al.
The Lancet. Healthy Longevity|July 23, 2021
Association between HIV and incident pulmonary hypertension in US Veterans: a retrospective cohort studyMeredith S Duncan, Charles W Alcorn, Matthew S Freiberg, et al.
EGEMS (Washington, DC)|June 9, 2018
A Framework for Leveraging "Big Data" to Advance Epidemiology and Improve Quality: Design of the VA Colonoscopy CollaborativeSamir Gupta, Lin Liu, Olga V Patterson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 29, 2005
Cancer chemotherapy and drug metabolismDavid S Riddick, Chunja Lee, Shairoz Ramji, et al.
Analytical Chemistry|April 8, 2020
Virus Bioresistor (VBR) for Detection of Bladder Cancer Marker DJ-1 in Urine at 10 pM in One MinuteApurva Bhasin, Emily C Sanders, Joshua M Ziegler, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2021
Restoring Tumour Selectivity of the Bioreductive Prodrug PR-104 by Developing an Analogue Resistant to Aerobic Metabolism by Human Aldo-Keto Reductase 1C3Maria R Abbattista, Amir Ashoorzadeh, Christopher P Guise, et al.
Molecular Cancer Therapeutics|December 8, 2011
Molecular and cellular pharmacology of the hypoxia-activated prodrug TH-302Fanying Meng, James W Evans, Deepthi Bhupathi, et al.
American Journal of Respiratory and Critical Care Medicine|November 14, 2017
Increased Echocardiographic Pulmonary Pressure in HIV-infected and -uninfected Individuals in the Veterans Aging Cohort StudyEvan L Brittain, Meredith S Duncan, Joyce Chang, et al.
Acta Pharmacologica Sinica|June 23, 2026
Development of XYD113 as a potent and highly selective GSPT1 degrader for cancer therapyHui Shen, Xiao-Yu Luo, Xin-Yi Jing, et al.
Biochemical Pharmacology|January 18, 2014
A novel fluorometric assay for aldo-keto reductase 1C3 predicts metabolic activation of the nitrogen mustard prodrug PR-104A in human leukaemia cellsStephen M F Jamieson, Yongchuan Gu, Donya Moradi Manesh, et al.
Pageof 28